European Archives - Page 97 of 1211 - European Medical Journal

Treatment Methods Compared for Overactive Bladder in MS

Findings suggest that both TPTNS and rTMS may have value in symptom management and quality-of-life improvement in MS patients with neurogenic OAB.

Anti-Inflammatory Therapy Reduces Vascular Risk in Rheumatoid Arthritis

Anti-inflammatory treatment in RA patients significantly reduced biomarkers like IL-8 and E-selectin, with PET/CT imaging confirming corresponding decreases in arterial inflammation.

Study Confirms Airborne Spread of H5N1 Influenza Virus

A recent study confirms that an H5N1 avian influenza virus isolated from a dairy farm worker can spread through the air between mammals.

Major Treatment Gap for Drug-Resistant Infections in Low/Middle-Income Countries

A major treatment gap for life-threatening carbapenem-resistant Gram-negative bacterial infections has been revealed across eight low- and middle-income countries.

Breakthrough in Human Antibodies for Snakebite Treatment

Each year, up to 138,000 people die and around 400,000 more are left permanently disabled from snakebites.

Trump’s drug pricing order hits pharma stocks

Trump’s “most-favoured nation” drug pricing plan shakes pharma markets, sparking losses for US and EU firms.

Eosinophilic Inflammation Identifies Treatable Subtype of COPD

A new study identifies airway eosinophilia as a distinct, corticosteroid-responsive subtype of COPD, marked by heightened type 2 inflammation and gene expression changes.

Preparing for the Next Outbreak: Interview with Maria Zambon

The UK Health Security Agency (UKHSA) is an executive government agency, sponsored by the Department of Health and Social…

Cannabis in Pregnancy Linked to Poor Neonatal Outcomes

Cannabis use during pregnancy significantly increases the risk of low birth weight, preterm birth, and other poor neonatal outcomes, even after adjusting for tobacco use, a major meta-analysis finds.

Heart Scans May Guide Life-Saving Treatments for Coronary Artery Disease

Imaging findings help guide targeted medical therapy for coronary artery disease, improving survival in selected patient groups.